- Home
- REPX vs TLRY Comparison
REPX vs TLRY Comparison
Compare REPX & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPX
- TLRY
- Stock Information
- Founded
- REPX 2016
- TLRY N/A
- Country
- REPX United States
- TLRY Canada
- Employees
- REPX N/A
- TLRY N/A
- Industry
- REPX Oil & Gas Production
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- REPX Energy
- TLRY Health Care
- Exchange
- REPX Nasdaq
- TLRY Nasdaq
- Market Cap
- REPX 568.6M
- TLRY 637.2M
- IPO Year
- REPX N/A
- TLRY 2018
- Fundamental
- Price
- REPX $26.59
- TLRY $0.43
- Analyst Decision
- REPX Strong Buy
- TLRY Hold
- Analyst Count
- REPX 1
- TLRY 3
- Target Price
- REPX $47.00
- TLRY $1.38
- AVG Volume (30 Days)
- REPX 85.7K
- TLRY 24.0M
- Earning Date
- REPX 05-07-2025
- TLRY 04-08-2025
- Dividend Yield
- REPX 5.73%
- TLRY N/A
- EPS Growth
- REPX N/A
- TLRY N/A
- EPS
- REPX 4.67
- TLRY N/A
- Revenue
- REPX $412,894,000.00
- TLRY $826,656,000.00
- Revenue This Year
- REPX $2.86
- TLRY $10.11
- Revenue Next Year
- REPX $4.05
- TLRY $5.88
- P/E Ratio
- REPX $5.68
- TLRY N/A
- Revenue Growth
- REPX 1.25
- TLRY 11.22
- 52 Week Low
- REPX $21.98
- TLRY $0.41
- 52 Week High
- REPX $37.55
- TLRY $2.31
- Technical
- Relative Strength Index (RSI)
- REPX 50.27
- TLRY 34.40
- Support Level
- REPX $24.31
- TLRY $0.41
- Resistance Level
- REPX $26.03
- TLRY $0.52
- Average True Range (ATR)
- REPX 1.02
- TLRY 0.03
- MACD
- REPX 0.26
- TLRY 0.00
- Stochastic Oscillator
- REPX 68.58
- TLRY 16.18
About REPX Riley Exploration Permian Inc.
Riley Exploration Permian Inc is engaged in the business of exploration for and production of oil and natural gas. The company operations are in Kansas Properties and Tennessee Properties, among others.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.